NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
Back to search
Official data from USPTO
BIOLAB FARMACEUTICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
06/06/2023
Trademark type
Combined
Nice classes
3, 5
Filing date
09/24/2021
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
16
Owner location
São Paulo, BR
Examiner
MUNN LEWIS, LAKEISHA S
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized and stacked wording "BIOLAB FARMACÊUTICA" in blue with a stylized droplet shape to the right of the wording. The droplet has blue, light green, and dark green stripes. The color white in the mark represents background, outlining, shading and/or transparent areas and is not claimed as a feature of the mark.
Holders and representatives
Holders
BIOLAB SANUS FARMACÊUTICA LTDA.
Representatives
Melissa A. Nowak CHRISTENSEN O'CONNOR JOHNSON KINDNESS
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetic preparations; cosmetic products for skincarefacial cleaning preparationsacne foam cleansers and facial moisturizersnot for medical purposes; cosmetic preparations for sun protection; hair lotions; preparations for nail care; facial soaps being skin soap; toilet productsmoisturizing preparations for the skin
Class 5
Medicines for human and veterinary usepharmaceutical and veterinary pharmaceutical preparations for in the treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary system for the treatment of inflammatory disorders and for use in dermatologyantifungaloncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; adjuvants for medical purposes; pharmaceutical preparations for human and veterinary use for the treatment and prevention of disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary system for the treatment of inflammatory disorders and for use in dermatologyantifungaloncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; chemical-pharmaceutical preparations for the treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculoskeletal systemthe genitourinary system for the treatment of inflammatory disorders and for use in dermatologyantifungaloncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; nutritional complements in the nature of nutritional supplements; mineral food supplements; vitamins and mineral supplements; dietetic foodcerealspowdered milk for babiessaltsugar adapted for medical use
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
DOCK
ASSIGNED TO EXAMINER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2023
ALIE
ASSIGNED TO LIE
01/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/18/2022
GNRT
NON-FINAL ACTION E-MAILED
07/18/2022
CNRT
NON-FINAL ACTION WRITTEN
07/18/2022
DOCK
ASSIGNED TO EXAMINER
06/25/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2021
NWAP
NEW APPLICATION ENTERED
09/28/2021
Continuous trademark protection
Get notified about every new filing that threatens BIOLAB FARMACEUTICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.